Koen Van Laere

Prof. Dr. Koen Van Laere

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2009 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
AVAndrea Varrone
Andrea Varrone
SASusanne Asenbaum
Susanne Asenbaum
TBThierry Vander Borght
Thierry Vander Borght
JBJan Booij
Jan Booij
FNFlavio Nobili
Flavio Nobili
KLKoen Van Laere
Koen Van Laere

17 November 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
RBRobbert Boudewijns
Robbert Boudewijns
HTHendrik Jan Thibaut
Hendrik Jan Thibaut
SKSuzanne Kaptein
Suzanne Kaptein
RLRong Li
Rong Li
VVValentijn Vergote
Valentijn Vergote
KDKai Dallmeier
Kai Dallmeier
Emergence of SARS-CoV-2 causing COVID-19 has resulted in hundreds of thousands of deaths. In search for key targets of effective therapeutics, robust animal models mimicking COVID-19 in humans are urgently needed. Here, we show that Syrian hamsters, in contrast to mice, are highly permissive to SARS-CoV-2 and develop bronchopneumonia and strong inflammatory responses in the lungs with neutrophil infiltration and edema, further confirmed as consolidations visualized by micro-CT alike in clinical practice. Moreover, we identify an exuberant innate immune response as key player in pathogenesis, in which STAT2 signaling plays a dual role, driving severe lung injury on the one hand, yet restricting systemic virus dissemination on the other. Our results reveal the importance of STAT2-dependent interferon responses in the pathogenesis and virus control during SARS-CoV-2 infection and may help rationalizing new strategies for the treatment of COVID-19 patients.

10 August 2004 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
KLKoen Van Laere
Koen Van Laere
SCSarah Ceyssens
Sarah Ceyssens
FCFrank Van Calenbergh
Frank Van Calenbergh
TGTjibbe de Groot
Tjibbe de Groot
JMJohan Menten
Johan Menten
LMLuc Mortelmans
Luc Mortelmans

1 December 2020 in Nature
Verified
Journal Article
Closed access
PDF file
LSLorena Sanchez-Felipe
Lorena Sanchez-Felipe
TVThomas Vercruysse
Thomas Vercruysse
SSSapna Sharma
Sapna Sharma
JMJi Ma
Ji Ma
VLViktor Lemmens
Viktor Lemmens
KDKai Dallmeier
Kai Dallmeier

9 August 2010 in BMC Neuroscience
Verified
Journal Article
Open access
PDF file
CVCaroline Vandeputte
Caroline Vandeputte
JTJean-Marc Taymans
Jean-Marc Taymans
CCCindy Casteels
Cindy Casteels
FCFrea Coun
Frea Coun
Yicheng NiYicheng Ni
Yicheng Ni
VBVeerle Baekelandt
Veerle Baekelandt
Background: Accurate and reproducible behavioral tests in animal models are of major importance in the development and evaluation of new therapies for central nervous system disease. In this study we investigated for the first time gait parameters of rat models for Parkinson's disease (PD), Huntington's disease (HD) and stroke using the Catwalk method, a novel automated gait analysis test. Static and dynamic gait parameters were measured in all animal models, and these data were compared to readouts of established behavioral tests, such as the cylinder test in the PD and stroke rats and the rotarod tests for the HD group. Results: Hemiparkinsonian rats were generated by unilateral injection of the neurotoxin 6-hydroxydopamine in the striatum or in the medial forebrain bundle. For Huntington's disease, a transgenic rat model expressing a truncated huntingtin fragment with multiple CAG repeats was used. Thirdly, a stroke model was generated by a photothrombotic induced infarct in the right sensorimotor cortex. We found that multiple gait parameters were significantly altered in all three disease models compared to their respective controls. Behavioural deficits could be efficiently measured using the cylinder test in the PD and stroke animals, and in the case of the PD model, the deficits in gait essentially confirmed results obtained by the cylinder test. However, in the HD model and the stroke model the Catwalk analysis proved more sensitive than the rotarod test and also added new and more detailed information on specific gait parameters. Conclusion: The automated quantitative gait analysis test may be a useful tool to study both motor impairment and recovery associated with various neurological motor disorders.

1 May 2014 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
KLKoen Van Laere
Koen Van Laere
AVAnnelies Vanhee
Annelies Vanhee
JVJolien Verschueren
Jolien Verschueren
LCLiesbeth De Coster
Liesbeth De Coster
ADAn Driesen
An Driesen
PDPhilip Van Damme
Philip Van Damme
Quiz Ref ID Motor neuron disorders (MNDs) comprise a group of disorders involving preferential damage to upper motor neurons (UMNs) and/or lower motor neurons (LMNs).1,2 In adulthood, the clinical spectrum of MNDs is wide, ranging from simultaneous involvement of UMNs and LMNs (classic amyotrophic lateral sclerosis [ALS], about 90% of all MND cases), a pure UMN syndrome (primary lateral sclerosis [PLS]), and an isolated LMN involvement (progressive muscular atrophy [PMA]).1 It has not been settled whether the latter 2 are entities fully separated from ALS because a considerable number of patients with PLS and PMA progress to ALS.